You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健之佳(605266.SH):不涉及對醫院的批發、分銷或藥房託管等業務,聚焦於藥店、便利店的全渠道專業連鎖零售業務
格隆匯 08-17 08:53

格隆匯8月17日丨有投資者向健之佳(605266.SH)提問,“國家推進的“醫藥分離”改革進度怎麼樣了?是否能有效防止醫院的腐敗問題?貴司是否有積極參與?”

健之佳回覆稱,隨着醫藥衞生體制改革的深入,醫藥分業、藥佔比、藥品零差價、分級診療、帶量集採、醫保雙通道等一系列醫藥改革措施的穩步推進步入常態化。2023年,國家醫保局發佈的《關於進一步做好定點零售藥店納入門診統籌管理的通知》,旨在發揮醫保門診醫藥費用保障功能,切實保障參保人員權益,提升就醫購藥便利性、可及性,擴大醫藥服務供給。公司積極做好政策的應對,支持醫藥分業改革措施落地。目前,各省配套政策正在制定、逐步落實中。國家立法機關、各監管部門提升行業合規水平、保障民眾健康的立法、執法、監管、改革工作持續深化,應能改進醫療和藥品流通領域的合規水平、提升效率和透明度。公司不涉及對醫院的批發、分銷或藥房託管等業務,聚焦於藥店、便利店的全渠道專業連鎖零售業務,在長期堅持合規運營的基礎上,圍繞顧客需求,通過醫藥、便利零售以及相關的專業服務,積極承接院內顧客、商品向社會藥房的流出,配合醫藥改革做好承接處方流轉、服務統籌結算顧客等後續工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account